Skip to main content
U.S. flag

An official website of the United States government

Fingolimod hydrochloride

Published by U.S. Food and Drug Administration | U.S. Department of Health & Human Services | Catalog Last Checked: September 10, 2026 at 08:30 PM | Dataset Last Updated: March 17, 2025
Fingolimod Hydrochloride is a generic prescription drug, equivalent to 0.5 mg of fingolimod base per capsule, used orally to treat relapsing forms of multiple sclerosis. Manufactured by Ascend Laboratories, LLC under ANDA208004, it modulates sphingosine 1-phosphate receptors to reduce immune cell migration into the central nervous system. This information was generated using AI and is provided for informational and research purposes only.

Resources

1 resource available

Find Related Datasets

Search by Tags

Click any tag below to search for similar datasets

data.gov

An official website of the GSA's Technology Transformation Services

Looking for U.S. government information and services?
Visit USA.gov